Goldman Sachs analyst Callie Valenti assumed coverage of Klaviyo with a Buy rating and $26 price target. The stock was down 30% after Q1 earnings, following an announced CFO departure and factors that caused noise around both sequential and y/y trends, but Klaviyo's exposure to a wide variety of growth vectors gives the firm some confidence in the health of the company's underlying business, particularly with revenue growth still in the high 20s, the analyst tells investors in a research note.
